NASDAQ:AZRX - AzurRx BioPharma, Inc.
$1.67
 $-0.05
-2.82%
1:50PM EDT
2019-02-15
AzurRx BioPharma, Inc. is a clinical development-stage biopharmaceutical company. The Company is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal (GI) disorders. The Company's product pipeline consists of two therapeutic proteins, such as MS1819 and AZX1101. MS1819 is an acid-resistant secreted lipase produced by Yarrowia lipolytica, known as LIP2, that the Company is developing through recombinant deoxyribonucleic acid (DNA) technology for the treatment of exocrine pancreatic insufficiency (EPI), associated with chronic pancreatitis (CP) and cystic fibrosis (CF). AZX1101 is a recombinant-lactamase combination of bacterial origin under development for the prevention of hospital-acquired infections by resistant bacterial strains induced by parenteral administration of b-lactam antibiotics (known as nosocomial infections), as well as the prevention of antibiotic-associated diarrhea (AAD). Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  AZRX     avg for
industry  
  avg for
sector  
42 stocks weight:  14. 30   0. 00   0. 00  
42 stocks rank:  3. 82 K 1. 86 K 1. 09 K
# analyst opinions:  3. 00   14. 92   14. 43  
mean recommendation:  1. 70   1. 91   1. 93  

quick ratio:  3. 84   5. 37   1. 81  
current ratio:  3. 88   5. 69   2. 19  

target price low:  1. 91   88. 97   117. 82  
target price avg:  2. 60   115. 19   141. 96  
target price high:  3. 34   143. 40   163. 16  
1-yr high:  3. 58   124. 30   142. 77  
last close:  1. 77   101. 85   127. 84  
50-day avg:  1. 89   98. 27   122. 46  
200-day avg:  2. 42   99. 72   122. 70  
1-yr low:  1. 05   78. 19   100. 16  
volume:  24. 45 K 2. 38 M 4. 64 M
50-day avg volume:  80. 32 K 3. 31 M 4. 94 M
200-day avg volume:  74. 78 K 3. 23 M 4. 28 M

1-day return:  3. 51 % 0. 22 % 0. 48 %
this week return:  -5. 85 % 1. 77 % 2. 01 %
12-wk return:  -16. 90 % 6. 56 % 3. 33 %
52-wk return:  -34. 08 % -2. 23 % 14. 35 %

enterprise value (EV):  27. 42 M 55. 17 B 104. 51 B
market cap:  31. 10 M 49. 01 B 96. 46 B
EBITDA:  -10. 64 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  -2. 58   -91. 79   2. 29  
total debt:  0. 00   13. 73 B 16. 57 B
net income (common):  -11. 99 M 2. 37 B 3. 58 B

shares outstanding:  17. 67 M 607. 99 M 1. 22 B
shares:  11. 16 M 605. 53 M 1. 15 B
shares short:  139. 76 K 11. 62 M 12. 55 M
shares short prior month:  94. 33 K 11. 95 M 13. 44 M
short ratio:  1. 30   4. 82   3. 10  
short % of float:  0. 98 % 6. 19 % 2. 82 %
total cash/share:  0. 26   12. 02   11. 46  
total cash:  4. 43 M 7. 41 B 7. 37 B
free cash flow:  -6. 77 M 95. 99 M 2. 04 B
operating cash flow:  -10. 00 M 164. 74 M 3. 04 B

book value:  0. 33   14. 43   28. 26  
price/book:  5. 41   -1. 57   -2. 97  
operating margins:  0. 00 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  0. 00 % 49. 33 % 54. 53 %

1-yr max volatility:  25. 38 % --- ---
1-yr mean volatility:  -0. 07 % 0. 01 % 0. 06 %

1-yr EPS:  -0. 85   3. 03   4. 09  
forward EPS:  -0. 61   4. 33   6. 99  
P/E:  -2. 08   6. 11   26. 91  
forward P/E:  -3. 08   8. 38   10. 48  
PE/G:  0. 09   0. 37   5. 61  
growth:  -23. 44 % 683. 72 % 104. 79 %
earnings high:  -0. 17   1. 27   1. 66  
earnings avg:  -0. 18   1. 01   1. 53  
earnings low:  -0. 20   0. 76   1. 40  
revenue high:  -0. 00   2. 86 B 11. 19 B
revenue avg:  -0. 00   2. 78 B 10. 84 B
revenue low:  -0. 00   2. 67 B 10. 64 B
return on assets:  -92. 81 % -3. 27 % 3. 81 %
return on equity:  -288. 07 % 107. 48 % 27. 82 %

beta (1yr vs S&P500):  0. 29   1. 21   0. 93  
sharpe (1yr):  -0. 22   0. 06   0. 98  

held % insiders:  36. 88 % 6. 46 % 3. 21 %
held % institutions:  19. 01 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : AZRX
.    + 0.477 =         0.477 :: INITIAL WEIGHT
.  + 637.725 =       638.203 :: inverse volume-to-price addition
.  + 393.827 =      1032.029 :: spline projection addition
.  - 192.639 =       839.391 :: poor performance penalty
.    x 0.739 =       620.693 :: one-year gains+dividend factor
.    x 1.665 =      1033.371 :: 13 weeks' performance factor
.    x 1.492 =      1542.295 :: industry recommendation factor
.    x 2.373 =      3659.336 :: symbol recommendation factor
.    x 0.991 =      3625.372 :: return on assets factor
.    x 0.971 =      3520.937 :: return on equity factor
.    x 2.681 =      9439.435 :: current ratio factor
.    x 1.163 =     10977.722 :: quick ratio factor
.     x 1.33 =     14601.736 :: short ratio factor
.    x 2.084 =     30424.329 :: price-to-book factor
.    x 2.164 =     65838.381 :: P/E weight
.    x 1.833 =    120701.448 :: PE/G factor
.    x 1.613 =    194655.398 :: beta factor
.    x 0.221 =     42937.587 :: sharpe factor
.    x 1.282 =     55056.083 :: target low factor
.    x 1.228 =     67627.702 :: target mean factor
.    x 1.094 =     74001.515 :: target high factor
.    x 1.066 =     78856.962 :: industry 12-weeks return
.    x 0.861 =     67864.178 :: "drift" penalty 1 days ago
.    x 0.897 =     60883.483 :: "drift" penalty 4 days ago
.    x 0.992 =      60409.61 :: overall "drift" factor
.    x 0.746 =     45074.863 :: largest single-day jump factor
.    x 0.065 =       2925.04 :: low price factor
.      x 1.0 =      2925.236 :: factor hist industry gain for week 06
.   cubeRoot =        14.302 :: reduced for readability
.                     14.302 :: FINAL WEIGHT for NASDAQ:AZRX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org